WA-AMAZON.COM-INC.
21.9.2022 15:11:03 CEST | Business Wire | Press release
Amazon (NASDAQ: AMZN) announced that it is expanding its renewable energy portfolio globally, with an additional 2.7 gigawatts (GW) of clean energy capacity across 71 new renewable energy projects. This includes the company’s first renewable energy project in South America—a solar farm in Brazil—and its first solar farms in India and Poland. Once fully operational, Amazon’s global renewable energy portfolio will generate 50,000 gigawatt hours (GWh) of clean energy, which is the equivalent amount of electricity needed to power 4.6 million U.S. homes each year.
“We are bringing new wind and solar projects online to power our offices, fulfillment centers, data centers, and stores, which collectively serve millions of customers globally, and we are on a path to reach 100% renewable energy across our entire business by 2025,” said Adam Selipsky, CEO of Amazon Web Services. “Around the world, countries are looking to accelerate the transition to a clean energy economy, and continued investments like ours can help accelerate their journey as we all work together to mitigate the impacts of climate change.”
As the largest corporate purchaser of renewable energy globally, Amazon now has a total of 379 renewable energy projects across 21 countries, including 154 wind and solar farms and 225 rooftop solar projects, representing 18.5 GW of renewable energy capacity. By the end of 2021, the company had reached 85% renewable energy across its business.
Amazon continues to successfully enable projects in power grids around the world, including:
- In the Asia-Pacific region, Amazon is announcing the company’s first three large-scale projects in India. All three are solar projects in Rajasthan, representing 420 megawatts (MW) of clean energy capacity. Amazon is scaling fast in India, and these first investments play a critical role in reducing our carbon emissions in the country. In the Asia-Pacific region, the company now has a total of 57 renewable energy projects.
- In Europe, Amazon now has 117 renewable energy projects. Amazon is announcing its first rooftop solar projects in France and Austria, and its first solar farm in Poland. Amazon’s investment in its first utility-scale project in Poland is one of the largest corporate solar deals announced to date in the country. With this commitment, Amazon is directly contributing to the Polish government’s goal of increasing renewable energy on its grid. Corporate support of new renewable energy projects like Amazon’s helps open up the market for additional wind and solar farms, and accelerates the decarbonization of the grid.
- In North America, Amazon is adding 1 GW of clean energy capacity across the Southeastern U.S., including the company’s first two renewable energy projects in Louisiana. The company now has a total of 202 projects across North America.
- In South America, Amazon is announcing its first renewable energy project, which is a 122 MW solar farm in Brazil. In addition to providing renewable power to Amazon’s operations in the region, this project will also provide economic benefits to the local economy and the region’s biodiversity. The project includes a $380,000 (R$2 million) investment in environmental programs during construction to protect and promote biodiversity. The project is estimated to create 850 jobs during the construction phase, with an additional 30 permanent jobs once the project becomes operational.
To help scale the benefits of investments in the renewable energy sector as it continues to grow, Amazon is also working through the Clean Energy Buyers Institute’s (CEBI) Beyond the Megawatt initiative to ensure the industry is maximizing the economic, environmental, and social impact of energy procurement.
“As a key leader in the CEBA community, Amazon continues to demonstrate that when it commits to a vision, it drives a pace and scale that’s a new bar to follow,” said Miranda Ballentine, CEO of Clean Energy Buyers Association (CEBA) and Clean Energy Buyers Institute (CEBI). “Amazon also continues to be a leader in not only deploying today’s clean energy procurement tools at scale, but also in leading its community of peers and partners in developing tomorrow’s clean energy solutions—whether that’s focusing on ensuring renewables have sustainable supply chains or expanding the impact of clean energy through next generation procurement tools.”
“With its landmark solar projects announced in Poland and France, Amazon has taken crucial steps towards its net-zero pledge, while supporting Europe’s own climate goals,” said Walburga Hemetsberger, CEO of SolarPower Europe, founding partner of the RE-Source Platform. “As Europe faces skyrocketing energy prices, solar and renewable energy deals will strengthen Amazon’s strategic resilience—we hope to see more companies follow Amazon’s lead.”
Amazon co-founded The Climate Pledge in 2019, committing to reach net-zero carbon by 2040—10 years ahead of the Paris Agreement. The Pledge now has more than 375 signatories, including Best Buy, IBM, Microsoft, PepsiCo, Siemens, Unilever, Verizon, and Visa. Amazon has also ordered 100,000 electric delivery vehicles, the largest order ever of electric delivery vehicles, and has started to roll them out across the U.S. The company is also investing $2 billion in the development of decarbonizing services and solutions through The Climate Pledge Fund. For more information, visit https://sustainability.aboutamazon.com/.
About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.
About Amazon Web Services
For over 15 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud offering. AWS has been continually expanding its services to support virtually any cloud workload, and it now has more than 200 fully featured services for compute, storage, databases, networking, analytics, machine learning and artificial intelligence (AI), Internet of Things (IoT), mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and application development, deployment, and management from 87 Availability Zones within 27 geographic regions, with announced plans for 21 more Availability Zones and seven more AWS Regions in Australia, Canada, India, Israel, New Zealand, Spain, and Switzerland. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—trust AWS to power their infrastructure, become more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220921005397/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom